Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| retinal rod cell | 9 studies | 50% ± 17% | |
| retinal bipolar neuron | 4 studies | 46% ± 18% | |
| OFF-bipolar cell | 3 studies | 31% ± 4% | |
| ON-bipolar cell | 3 studies | 26% ± 5% | |
| rod bipolar cell | 3 studies | 69% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 7 studies | 34% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| spleen | 88% | 10.98 | 212 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 81% | 32.86 | 752 / 929 | 0% | 0 | 0 / 0 |
| lung | 71% | 7.72 | 408 / 578 | 0% | 0.01 | 3 / 1155 |
| brain | 30% | 1.52 | 803 / 2642 | 0% | 0 | 0 / 705 |
| blood vessel | 20% | 0.58 | 272 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 19% | 0.59 | 150 / 803 | 0% | 0 | 0 / 0 |
| kidney | 18% | 0.44 | 16 / 89 | 0% | 0.01 | 4 / 901 |
| liver | 18% | 0.54 | 41 / 226 | 0% | 0 | 0 / 406 |
| thymus | 16% | 0.45 | 105 / 653 | 0% | 0 | 0 / 605 |
| adipose | 15% | 0.44 | 185 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 13% | 6.64 | 10 / 80 |
| prostate | 12% | 0.44 | 30 / 245 | 0% | 0 | 0 / 502 |
| breast | 12% | 0.32 | 54 / 459 | 0% | 0.00 | 1 / 1118 |
| heart | 11% | 0.31 | 93 / 861 | 0% | 0 | 0 / 0 |
| esophagus | 9% | 0.23 | 125 / 1445 | 1% | 0.03 | 2 / 183 |
| intestine | 7% | 0.17 | 70 / 966 | 1% | 0.01 | 3 / 527 |
| adrenal gland | 7% | 0.18 | 19 / 258 | 0% | 0 | 0 / 230 |
| stomach | 5% | 0.14 | 19 / 359 | 2% | 0.03 | 5 / 286 |
| uterus | 6% | 0.21 | 11 / 170 | 0% | 0 | 0 / 459 |
| skin | 5% | 0.43 | 90 / 1809 | 0% | 0.00 | 1 / 472 |
| ovary | 5% | 0.11 | 9 / 180 | 0% | 0 | 0 / 430 |
| pancreas | 2% | 0.05 | 8 / 328 | 0% | 0 | 0 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005246 | Molecular function | calcium channel regulator activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CABP5 |
| Protein name | Calcium-binding protein 5 (CaBP5) |
| Synonyms | CABP3 |
| Description | FUNCTION: Inhibits calcium-dependent inactivation of L-type calcium channel and shifts voltage dependence of activation to more depolarized membrane potentials (By similarity). Involved in the transmission of light signals (By similarity). May positively regulate neurotransmitter vesicle endocytosis and exocytosis in a salt-dependent manner (By similarity). May play a role in the extension and network organization of neurites (By similarity). . |
| Accessions | ENST00000293255.3 Q9NP86 |
